Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro

Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic liver disease globally, and the incidence of NAFLD has been increasing rapidly year by year. Currently, there is no effective pharmacotherapy for NAFLD. Therefore, studies are urgently needed to explore therapeutic drugs for NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yanze, Kang, Yixing, Yi, Jing, Lin, Qirui, Zhang, Chaochuang, Lin, Zewei, Yan, Zilong, Qu, Jianhua, Liu, Jikui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252632/
https://www.ncbi.nlm.nih.gov/pubmed/35795282
http://dx.doi.org/10.1155/2022/2122563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252632/
https://www.ncbi.nlm.nih.gov/pubmed/35795282
http://dx.doi.org/10.1155/2022/2122563

Ejemplares similares